Universal Ibogaine Inc. (IBO.V)

CAD 0.02

(0.0%)

Market Cap (In CAD)

4.12 Million

Revenue (In CAD)

1.07 Million

Net Income (In CAD)

-10.49 Million

Avg. Volume

34.87 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.005-0.03
PE
-
EPS
-
Beta Value
5.147
ISIN
CA91360F1099
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Nicholas Peter Karos
Employee Count
-
Website
https://universalibogaine.com
Ipo Date
2017-06-22
Details
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.